Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).

10 Feb 2010

Maternal obesity increases offspring's risk of developing inflammation-related disorders

As if there are not enough reasons for obese people to lose weight, a new research report published online in The FASEB Journal (http://www.fasebj.org), adds several more. In a study involving rats, researchers from Duke University found that obesity in mothers causes cellular programming in utero that predisposes offspring to inflammation-related disorders (such as Alzheimer's, Parkinson's, type 2 diabetes, stroke, heart disease, and more) from the day that they are born, regardless of whether or not the offspring are obese themselves.

10 Feb 2010

Kansas to downsize hospitals for disabled; Nevada may cut enrollment in programs for mentally ill and seniors

Kansas Health Institute reports on downsizing at hospitals for the developmentally disabled: "Admissions to Kansas Neurological Institute will be halted this summer and restricted at Parsons State Hospital, the state's top welfare agency official said today.

10 Feb 2010

Drinking milk during pregnancy can protect baby against multiple sclerosis

Drinking milk during pregnancy may help reduce your baby's chances of developing multiple sclerosis (MS) as an adult, according to a preliminary study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

10 Feb 2010

Study could lead to new therapeutic strategies for Parkinson's disease

A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate.

10 Feb 2010

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: “Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson’s Disease Biomarker” and is the second awarded to Targacept by MJFF in the last six months.

9 Feb 2010

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

A Mediterranean diet may help people avoid the small areas of brain damage that can lead to problems with thinking and memory, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

9 Feb 2010

New revolutionary treatment for patients suffering from movement disorders

Deep Brain Stimulation (DBS), a new treatment being offered at Geisinger Medical Center (GMC) and Geisinger Wyoming Valley Medical Center (GWV), can dramatically reduce symptoms of movement disorders.

9 Feb 2010

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

7 Feb 2010

TGen completes strategic alliance and affiliation agreement with VARI

The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes.

5 Feb 2010

iPSC technology for identifying agents that reprogram human somatic cells receives Notice of Allowance

Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.

5 Feb 2010

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

The Michael J. Fox Foundation for Parkinson's Research today announced more than $2.8 million in awards for 13 new projects to speed the discovery of biomarkers of PD.

4 Feb 2010

Immigrants may be healthier than long-term residents

New immigrants to North America may be less likely to have a stroke at a young age than long-time residents, according to a study published in the February 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Feb 2010

Ambassadors of Purple selected to help promote Purple Day for Epilepsy

As the third annual, worldwide Purple Day for Epilepsy approaches on March 26, 2010, organizers in Canada and in 15 other participating countries around the globe are looking for volunteers to promote epilepsy awareness in local communities.

3 Feb 2010

Researchers find three different degenerative brain disorders linked by toxic form of Elk-1 protein

For the first time, researchers from the University of Pennsylvania School of Medicine have found that three different degenerative brain disorders are linked by a toxic form of the same protein. The protein, called Elk-1, was found in clumps of misshaped proteins that are the hallmarks of Parkinson's disease, Alzheimer's disease, and Huntington's disease.

3 Feb 2010

Negative perceptions of speech patterns create social barriers for Parkinson's patients

People with Parkinson's disease suffer social difficulties simply because of the way they talk, a McGill University researcher has discovered. Marc Pell, at McGill's School of Communication Sciences and Disorders, has learned that many people develop negative impressions about individuals with Parkinson's disease, based solely on how they communicate.

3 Feb 2010

Simulation training may help improve driving skills of Parkinson's disease patients

In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents.

2 Feb 2010

Interim positive data from Phase IIa clinical study of SYN115 for Parkinson’s disease

Synosia Therapeutics today announced interim positive data from a Phase IIa clinical study of an adenosine 2a (A2a) receptor antagonist (SYN115) in Parkinson’s disease.

1 Feb 2010

Project A.L.S. and Robert Packard Center for ALS Research partner in $15M research initiative

Project A.L.S. (New York, NY) and the Robert Packard Center for ALS Research at Johns Hopkins University (Baltimore, MD) announced that they will partner on P2 ALS, a $15 million initiative designed to advance ALS (Lou Gehrig's disease) research exponentially over the next three years.

30 Jan 2010

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes in this second edition to Prof. Robert J. Lefkowitz (1943, New York, United States), investigator in the Department of Medicine at Duke University (United States).

29 Jan 2010

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Maternal obesity increases offspring's risk of developing inflammation-related disorders

Kansas to downsize hospitals for disabled; Nevada may cut enrollment in programs for mentally ill and seniors

Drinking milk during pregnancy can protect baby against multiple sclerosis

Study could lead to new therapeutic strategies for Parkinson's disease

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

New revolutionary treatment for patients suffering from movement disorders

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

TGen completes strategic alliance and affiliation agreement with VARI

iPSC technology for identifying agents that reprogram human somatic cells receives Notice of Allowance

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

Immigrants may be healthier than long-term residents

Ambassadors of Purple selected to help promote Purple Day for Epilepsy

Researchers find three different degenerative brain disorders linked by toxic form of Elk-1 protein

Negative perceptions of speech patterns create social barriers for Parkinson's patients

Simulation training may help improve driving skills of Parkinson's disease patients

Interim positive data from Phase IIa clinical study of SYN115 for Parkinson’s disease

Project A.L.S. and Robert Packard Center for ALS Research partner in $15M research initiative

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in